• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Gabion Technologies India Ltd
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
544675
INE1H1501013
41.463033
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.58
160.8
EPS(TTM)
Face Value()
Div & Yield %
6.05
10
0
 

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit
Aug 22,2026
Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.